Other Streetwise ReportsThe Gold Report The Energy Report The Life Sciences Report The Mining Report
"The combination of DMPI's VAL-083 and radiation therapy showed an immediate survival benefit in glioblastoma multiforme." (10/30/14) DelMar Pharmaceuticals Inc. - The Life Sciences Report Interview with Brandon Primack More >
Dhesh S.K. Govender is a portfolio manager for healthcare and life sciences with the Cedar Lane Fund, a division of New York-based Cedar Lane Enterprises.
Big Pharma Will Find Good Hunting Among Early-Stage Biotechs: Dhesh Govender (2/13/14) Dhesh Govender, manager of the life sciences portfolio for Cedar Lane Enterprises Inc., has the inside track when it comes to identifying the hottest biotech trends. In this interview with The Life Sciences Report, Govender explains why he thinks plenty of upside remains in the life sciences sector, and reveals trade secrets that every investor should consider when building a successful investment strategy.